Small molecule · Transplant Immunology

Cyclosporine

Neoral
Small moleculeCalcineurin inhibitor (immunosuppressant)

PubChem CID 5284373 · 3D model

Drag to rotate. Scroll or pinch to zoom.

Blocks a signal inside immune T cells that would normally tell them to multiply and attack, which is why it's used to stop the body from rejecting a transplanted organ or attacking its own tissue in autoimmune disease.

How it works

Cyclosporine calms down T cells, the immune cells responsible for attacking foreign tissue like a transplanted organ. Inside a T cell, cyclosporine latches onto a protein called cyclophilin, and together they block a second protein, calcineurin, that normally acts as a switch telling the cell to start multiplying and mounting an attack. With that switch blocked, T cells stop receiving the signal to multiply. Cyclosporine doesn't kill immune cells — it just keeps them quiet, which is why it has to be taken continuously in transplant patients.

What it’s used for

Cyclosporine (Neoral) is used to stop the body from rejecting a transplanted kidney, liver, or heart, usually alongside other anti-rejection medicines. It's also prescribed for severe rheumatoid arthritis that hasn't improved enough with methotrexate, and for severe plaque psoriasis that hasn't responded to other treatments.

Mechanism
Calcineurin (immunosuppressant)
Drug class
Therapeutic area
Transplant Immunology

Related drugs